Varga et al. [44] retrospectively analyzed the role of the rs28362491 NFKB1 polymorphism, an insertion/deletion variant, on the survival of 295 MM patients treated with bortezomib. The gene discussed is NFKB1; the disease is Miyoshi myopathy.